Arbuthnot Banking - Renewal of Tier 2 Regulatory Capital Loan facility
Announcement provided by
Arbuthnot Banking Group PLC · ARBB19/12/2023 14:06
19 December 2023
Arbuthnot Banking Group PLC
Renewal of Tier 2 Regulatory Capital Loan facility
Arbuthnot Banking Group PLC ("ABG", the "Company" or the "Group") announces today that it has reached agreement to renew the private issue of its sub ordinated loan ("the Loan") issued on a bilateral basis to Proventus Capital Partners, a Swedish Debt fund (originally announced on 3 June 2019). The Loan is being increased by
The Loan is expected to be drawn on 3 June 2024 which is the fifth anniversary of the initial loan. The Loan is expected to mature on 3 June 2034 but can be repaid by ABG after the fifth anniversary. Interest is payable on the Loan at a rate of 7.25% plus SONIA.
Repayment of the initial loan and issuance of the Loan as part of the capital resources of the Group is subject to approval by the Prudential Regulation Authority. A further announcement will be made in due course.
It is expected this will be classified as Tier 2 for capital purposes and will maintain the current levels of capital to support the strategic plans of the Group.
The Directors of the Company accept responsibility for the contents of this announcement.
The information contained within this announcement is deemed to constitute inside information as stipulated under the retained EU law version of the Market Abuse Regulation (EU) No. 596/2014 (the "
|
|
ENQUIRIES: |
|
|
|
Arbuthnot Banking Group |
020 7012 2400 |
Sir Henry Angest, Chairman and Chief Executive |
|
Andrew Salmon, Group Chief Operating Officer |
|
James Cobb, Group Finance Director |
|
|
|
Grant Thornton |
020 7383 5100 |
Colin Aaronson |
|
Samantha Harrison |
|
Ciara Donnelly |
|
|
|
Shore Capital (Broker) |
020 7408 4090 |
Daniel Bush |
|
David Coaten |
|
Tom Knibbs |
|
|
|
H/Advisors Maitland (Financial PR) |
020 7379 5151 |
Sam Cartwright Neil Bennett |
|
|
|
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.